Skip to main content

Oncology Value Sets

NeoplasmObservationVS

Description TBD

Code Display CodeSystem
All codes descending from 108369006 Neoplasm (morphologic abnormality) http://snomed.info/sct

NeoplasmObservationMethodVS

Description TBD

Code Display CodeSystem
All codes descending from 386053000 Evaluation Procedure http://snomed.info/sct

BreastCancerTypeVS

Description TBD

Code Display CodeSystem
All codes descending from 126926005 Neoplasm of the breast (disorder) http://snomed.info/sct

ReceptorVS

Description TBD

Code Display CodeSystem
All codes descending from 116647005 Receptor (substance) http://snomed.info/sct

NottinghamCombinedGradeVS

Description TBD

Code Display CodeSystem
369790002 Low grade or well differentiated http://snomed.info/sct
369791003 Intermediate/moderate grade or moderately differentiated http://snomed.info/sct
369792005 High grade or pooly differentiated http://snomed.info/sct

LymphSystemSubdivisionVS

Description TBD

Code Display CodeSystem
All codes descending from 123849002 Lymphoid system subdivision (body structure) http://snomed.info/sct

HER2MethodVS

Description TBD

Code Display CodeSystem
74885-5 Tissue by Fluorescent in situ hybridization (FISH) http://loinc.org
spot-light SPot-Light HER2 CISH test HER2MethodCS
ihc ImmunoHistoChemistry test HER2MethodCS
inform Inform HER2 Dual ISH test (In SituHybridization) HER2MethodCS

DegreeOfLymphaticInvolvementVS

Description TBD

Code Display CodeSystem
microscopic Only a few cancer cells are in the node. DegreeOfLymphaticInvolvementCS
gross The cancer can be seen or felt without aid of microscopy. DegreeOfLymphaticInvolvementCS
extracapsular Cancer has pread outside the wall of the node. DegreeOfLymphaticInvolvementCS

GeneIdentifierVS

Description TBD

Code Display CodeSystem
All codes found in CodeSystem http://www.genenames.org http://www.genenames.org http://www.genenames.org

SubjectiveProgressionVS

Description TBD

Code Display CodeSystem
C0677874 Complete response or remission; no measurable or observable evidence of cancer. http://ncimeta.nci.nih.gov
C0015250 Complete resection/excision of cancerous tumor http://ncimeta.nci.nih.gov
C1272745 Improving, responding to treatment http://ncimeta.nci.nih.gov
C0205360 Stable, neither improving nor worsening http://ncimeta.nci.nih.gov
C1546960 Worsening, disease progressing http://ncimeta.nci.nih.gov
C3858734 Insufficient evidence http://ncimeta.nci.nih.gov

ProgressionEvidenceTypeVS

Description TBD

Code Display CodeSystem
C0011923 Progression determined based on imaging http://ncimeta.nci.nih.gov
C0030664 Progression determined based on pathology http://ncimeta.nci.nih.gov
C1457887 Progression determined based on physical signs or symptoms http://ncimeta.nci.nih.gov
C0031809 Progression determined based on physical examination http://ncimeta.nci.nih.gov
C0005516 Progression determined based on biomarkers http://ncimeta.nci.nih.gov

TumorMarginDescriptionVS

Description TBD

Code Display CodeSystem
129738007 Lesion with circumscribed margin http://snomed.info/sct
129741003 Lesion with indistinct margin http://snomed.info/sct
129739004 Lesion with microlobulated margin http://snomed.info/sct
129740002 Lesion with obscured margin http://snomed.info/sct
129742005 Lesion with spiculated margin http://snomed.info/sct

StagingTimeVS

When staging was done, relative to treatment events.

Code Display CodeSystem
clinical On initial diagnosis StagingTimeCS
pathologic Post-operative, after resection surgery StagingTimeCS
enrollment When patient is enrolled in a clinical trial StagingTimeCS
recurrence Upon recurrence of disease StagingTimeCS

TubuleFormationScoreVS

Description TBD

Code Display CodeSystem
369778004 Breast tubule formation: Majority of tumor >75% (score = 1) http://snomed.info/sct
369779007 Breast tubule formation: Moderate 10% to 75% (score = 2) http://snomed.info/sct
369780005 Breast tubule formation: Minimal <10% (score = 3) http://snomed.info/sct

NuclearPleomorphismScoreVS

Description TBD

Code Display CodeSystem
384735004 Nuclear pleomorphism: small regular nuclei (score=1) http://snomed.info/sct
384737007 Nuclear pleomorphism: moderate increase in size, etc (score = 2) http://snomed.info/sct
384738002 Nuclear pleomorphism: marked variation in size, nucleoli, chromatin clumping, etc (score = 3) http://snomed.info/sct

ToxicReactionVS

Description TBD

Code Display CodeSystem
C1519275 Severe Adverse Event. Daily activity is markedly reduced; some assistance usually required; medical intervention/therapy required, hospitalization or hospice care possible. http://ncimeta.nci.nih.gov
C1517874 Potentially Life-Threatening Adverse Event. Extreme limitation to daily activity, significant assistance required; significant medical intervention/therapy, hospitalization or hospice care very likely. http://ncimeta.nci.nih.gov
C1559081 Fatal Adverse Event. Adverse event associated with death http://ncimeta.nci.nih.gov